Aptar CSP Technologies has announced a new manufacturing site able to produce its Activ-Blister Solutions for oral slide dose drugs in Europe.
Aptar CSP Technologies is apart of AptarGroup, Inc. and one of the leaders in active material science solutions to ensure product protection, extend shelf life and improve patient experience. The move is part of a key strategic effort to expand production of Activ-Blister technology globally and is the result of a 3-way collaboration between Aptar CSP, Uhlmann (a leading pharmaceutical packaging equipment manufacturer), and Ivers-Lee, www.iverslee.com, (a local contract manufacturing organisation).
Badre Hammond, VP Commercial Operations and GM APAC, Aptar CSP Technologies said, “Expanding global manufacturing sites for Activ-Blister technology reflects our commitment to delivering global access to innovative active material science solutions for patients and consumers. “Expanding global manufacturing sites for Activ-Blister technology reflects our commitment to delivering global access to innovative active material science solutions for patients and consumers.”
Activ-Blister Solutions integrates Aptar CSP’s proprietary 3-Phase Activ-Polymer platform technology into individual blister cavities to provide precision microclimate protection for sensitive drug products. This technology can be customised specifically for the drug developer’s formulation to provide a broad spectrum of specific drug protection including moisture adsorption, and oxygen and odor scavenging. The technology can also scavenge volatile organic compounds (VOCs) and emit aromas.
Representatives from Aptar CSP Technologies will be available at Pharmapack today and tomorrow in Paris, France to provide more information on this collaboration and the opportunities it presents.